Selective growth inhibition against IL-6 dependent cells was detected in fermentation extracts of a fungal strain FO-4649which was characterized as Sporothrix species. An active metabolite (1) termed chlovalicin was isolated together with ovalicin and two other ovalicin derivatives (compounds 3 and 4). Chlovalicin, a ovalicin derivative with a chlorinated methylene moiety at the C-l position of the cyclohexane ring, dose-dependently inhibited the growth of IL-6 dependent MH60cells (IC50, 7.5fiM) in the presence of 0.2U/ml IL-6 and, to a lesser extent, the growth of B16 melanoma cells (IC50, 38 fiM). Amongthe other three compounds, only ovalicin showed inhibitory activity (IC50, 27jjm) against MH60cells. These four compounds did not show any antimicrobial activity at a concentration of 1000^g/ml.
In the course of a screening program for newtypes of antibiotics showing cytocidal activity, four structurally related compoundswere discovered from the fermentation broth of Sporothrix sp. FO-4649, which was isolated from a soil sample. One appeared to be a new compound and was designated as chlovalicin (1) , and the other compounds were identified as ovalicin (2) and its derivatives (3, 4) 1>2) ( Fig. 1 ). The present paper outlines taxonomic studies of the producing strain, and the production, isolation and biological activity of the new compound, chlovalicin.
Materials and Methods

General Experimental Procedures
The fungal strain FO-4649, isolated from a soil sample, was used for production of chlovalicin (1) . DC-Alufolien Kieselgel 60F254 (Merck) was used for TLC analysis.
HPLCwas carried out using the HITACHI D-2000 system and an ODSpacked column (Senshu Pak Pegasil ODS, 5/urn, i.d. 20x250mm ).
Taxonomic Studies
The fungal strain FO-4649 was originally isolated from a soil sample. For identification of the fungi, potato-dextrose agar, malt extract agar, Czapek's agar and lcA (Miura's medium) agar were used. Morphology was observed by microscopy (Olympus Vanox-S AH-2).
Antimicrobial Activity Antimicrobial activity was tested using paper disks and incubated for 24hours at 37°C in a 5% CO2-95% air atmosphere. To each well was added 5jal of medium containing different concentrations of chlovalicin. After 72 hour incubation, the cell growth was measured colorimetrically by the tetrazolium salt (MTT) method3).
MH60 cells (5 x 103 cells) suspended in 100/A ofRPMI 1640 medium supplemented with 10% FCS were plated in a 96-well culture plate and incubated with 5fA of test samples for 72hours at 37°C in the presence of 0.02U rhIL-6 (100//I) in a 5% CO2-95% air atmosphere. The cell growth was evaluated by the MTTmethod.
Results and Discussion
Taxonomyof Producing Organism
The fungal strain FO-4649 was isolated from a soil sample. For identification of the fungi, potato-dextrose agar, malt-extract agar, Czapek's agar and lcA (Miura's medium) agar were used. This strain grew moderately to form oyster white to light brownish gray colonies with a diameter of 20~40 mmafter inoculation for 7days at 25°C. The colony surface was floccose on various agar media. The reverse color was pale yellow to grayish white. Morphological observation was done under a microscope (Olympus Vanox-S AH-2). When the strain FO-4649was grown on potato-dextrose agar at 25°C for 7 days, the conidia were formed by blastoconidia from direct substrate hyphae and sympodioconidia Bar represents 20 um. JULY 1996 from conidiophores. Conidia were obovoid or obpyriform, smooth, hyaline to slightly colored, unicellular, 5~l2 x 3~6fim in diameter. The temperature permitting growth of the strain was 12 to 35°C, and optimum temperature for growth was 15 to 30°C. A light micrograph of this strain is shown in Fig. 2 was transferred to 100ml of production medium (100x 100ml) consisting of glucose 1.0%, tryptone 0.5%, yeast extract 0.3%, maltose 0.3%, and agar 0.1%, (adjusted to pH 6.5 before sterilization) in a 500-ml Erlenmeyer flasks, and the fermentation was carried out at 27°C for 6days with an agitation rate of 200 rpm. Detection of the chlovalicin in the fermentation broth was followed by growth inhibition on the IL-6 responsive cell system. After 6 days of fermentation, the amount of chlovalicin in the broth filtrate reached a maximum (0.35 /ig/ml).
Extraction and Isolation of Active Compounds
The culture broth (10 liters) of Sporothrix sp. was filtered, the resulting supernatant was extracted with EtOAc (10 liters x 2) and then the organic layer was dried with Na2SO4 anhydride. Science Co. LTD., Japan; solvent: 50% aq CH3CN: UV 210nm, flow rate 7ml/minute). Pure chlovalicin (1) (3.5mg), ovalicin (2) (12.3mg), compound 3 (2.5mg) and compound 4 (2.6mg) were obtained. Structures of chlovalicin and the related compounds are shown in Fig. 1 . Studies on the structural determination of chlovalicin will be reported in a separate paper.
Biological Activity
Growth inhibitory activity of chlovalicin was examined using various mammalian cells in vitro (Fig. 3) .
The antibiotic markedly inhibited growth of dependent MH60cells in a dose dependent manner. The IC50 values for MH60and B16 melanoma were 5.7/im and 38 jum, respectively. While the IC50 values for P388/S leukemia, P388 leukemia/ADM, HeLa S3 carcinoma and L929 fibroblast were all more than 75 /iM.
The cytotoxicities of chlovalicin, ovalicin and other related compounds against IL-6 dependent MH60cells were further examined. MH60cells were incubated with chlovalicin, ovalicin, compound3, or compound4 for 72hours in the presence of 0.2U/ml of IL-6. As shown in Fig. 4 , chlovalicin showed higher activity about 3 times of ovalicin (IC50, 27jum) but compound 3 and compound4 were not active. Chlovalicin dose-dependently inhibited the growth of IL-6 dependent MH60cells (IC50, 7.5 /xm) in the presence of IL-6. MH60cells seemed the most sensitive among these cells lines, so it is not clear whether chlovalicin selectively inhibits the IL-6 activity.
Further examinations are necessary to clarify the mechanism of chlovalicin and the specificity for other cytokines.
It has been suggested that abnormal IL-6 production is closely related to the progression of cancer cachexia6~8) and hormone-dependent hypercalcemia9'10), and to the development of multiple myeloma11>12) and rheumatoid arthritis13'14). Only a few substances are known to suppress IL-6 activity, i.e., suramin15) and monoclonal antibodies16).
Therefore, IL-6 inhibitors will be useful in studying its role in disease. Besides our present report concerning the inhibitory effect of chlovalicin on IL-6-dependent cell growth, recently, a new activity of chlovalicin as IgE production inhibitor was reported17). Therefore, chlovalicin is expected to be a newtype anti-allergic drug possessing the inhibitory effects to both IgE production and IL-6 activities.
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